Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-17 Meckler Jeffrey A Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Baynes Roy D. Director Grant or award +2,500 6,500
2017-05-17 Baynes Roy D. Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Coughlin Timothy P Director Grant or award +2,500 24,500
2017-05-17 Coughlin Timothy P Director Grant or award · Employee Stock Option (Right to Buy) +10,000 10,000
2017-05-17 Clague Laura Chief Financial Officer Grant or award · Employee stock option (right to buy) +60,000 60,000
2017-05-17 McFarlane Neil F. Chief Operating Officer Grant or award · Employee stock option (right to buy) +90,000 90,000
2017-05-17 ASELAGE STEVE Chief Executive Officer Grant or award · Employee stock option (right to buy) +165,000 165,000
2017-04-10 Squarer Ron Director Grant or award +4,375 4,375
2017-04-10 Squarer Ron Director Grant or award · Stock Option (Right to Buy) +17,500 17,500
2017-03-23 Orwin John A Director Grant or award +4,375 4,375
2017-03-23 Orwin John A Director Grant or award · Stock Option (Right to Buy) +17,500 17,500
2017-02-13 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +10,000 10,000
2017-02-13 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000
2017-01-04 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +10,000 10,000
2017-01-04 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Employee Stock Options (Right to Buy) +50,000 50,000
2016-11-22 ASELAGE STEVE Chief Executive Officer Sale −3,200 $21.30 $68K 240,556
2016-11-21 ASELAGE STEVE Chief Executive Officer Gift −57,000 248,756
2016-11-21 ASELAGE STEVE Chief Executive Officer Sale −5,000 $21.00 $105K 243,756
2016-09-01 Shih Alvin EVP of Research & Development Sale −8,750 $16.24 $142K 158,334

Page 53 of 59 · 1,174 trades